The Life Sciences team has eight dedicated employees. It is deeply involved with its investments, which take significant holdings of 15% to 25% of capital for a period of two to six years. It also has a consistent presence on company boards.
To date, our teams have invested in over 50 companies, leading to the creation of more than 2,000 jobs. The companies have brought a dozen new medical products and devices to market, which are now available to patients. Four generations of funds have been launched on this theme.